These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 20218800

  • 1. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadone.
    Wedekind D, Jacobs S, Karg I, Luedecke C, Schneider U, Cimander K, Baumann P, Ruether E, Poser W, Havemann-Reinecke U.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):390-9. PubMed ID: 20218800
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

  • 3. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT, Tait RJ, Hulse GK.
    J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
    [Abstract] [Full Text] [Related]

  • 4. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [Abstract] [Full Text] [Related]

  • 5. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E, Schreiber S, Naumovsky Y, Adelson M.
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [Abstract] [Full Text] [Related]

  • 6. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M, Weizman T, Melamed Y, Adelson M, Bleich A.
    Isr J Psychiatry Relat Sci; 2006 Apr; 43(2):126-36. PubMed ID: 16910375
    [Abstract] [Full Text] [Related]

  • 7. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J.
    Psychopathology; 2010 Apr; 43(2):88-95. PubMed ID: 20068379
    [Abstract] [Full Text] [Related]

  • 8. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 9. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients.
    Schreiber S, Peles E, Adelson M.
    Drug Alcohol Depend; 2008 Jan 01; 92(1-3):79-85. PubMed ID: 17706374
    [Abstract] [Full Text] [Related]

  • 10. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT).
    Peles E, Schreiber S, Adelson M.
    Eur Neuropsychopharmacol; 2008 Mar 01; 18(3):188-93. PubMed ID: 17997285
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine treatment of cocaine abuse in heroin addicts.
    Pollack MH, Rosenbaum JF.
    J Clin Psychiatry; 1991 Jan 01; 52(1):31-3. PubMed ID: 1988415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, Gerra ML, Amore M, Manfredini M, Donnini C, Somaini L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):483-9. PubMed ID: 21147192
    [Abstract] [Full Text] [Related]

  • 14. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.
    Encephale; 2009 Jun 30; 35(3):226-33. PubMed ID: 19540408
    [Abstract] [Full Text] [Related]

  • 15. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD.
    Drug Alcohol Depend; 2007 Sep 06; 90(1):64-71. PubMed ID: 17386981
    [Abstract] [Full Text] [Related]

  • 16. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
    Hoell I, Havemann-Reinecke U.
    Med Monatsschr Pharm; 2011 Oct 06; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
    [Abstract] [Full Text] [Related]

  • 17. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X, Launay C, Dervaux A, Kanit M.
    Encephale; 2009 Jun 06; 35(3):220-5. PubMed ID: 19540407
    [Abstract] [Full Text] [Related]

  • 18. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F, Shannon J.
    J Addict Dis; 1995 Jun 06; 14(1):67-74. PubMed ID: 7632748
    [Abstract] [Full Text] [Related]

  • 19. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I, Pani PP, Pacini M, Perugi G.
    J Subst Abuse Treat; 2007 Jul 06; 33(1):91-8. PubMed ID: 17588494
    [Abstract] [Full Text] [Related]

  • 20. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment.
    Maremmani I, Pacini M, Pani PP, Popovic D, Romano A, Maremmani AG, Deltito J, Perugi G.
    J Addict Dis; 2009 Oct 06; 28(4):382-8. PubMed ID: 20155607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.